scholarly article | Q13442814 |
P356 | DOI | 10.1097/00075484-200510000-00005 |
P698 | PubMed publication ID | 16215448 |
P2093 | author name string | Ricardo Muñoz | |
Alan Bostrom | |||
Victor I Reus | |||
Gary L Humfleet | |||
James M Lightwood | |||
Sharon M Hall | |||
P2860 | cites work | A randomized trial of nortriptyline for smoking cessation | Q34475866 |
Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine | Q41155678 | ||
Foundations of Cost-Effectiveness Analysis for Health and Medical Practices | Q41231603 | ||
Psychological intervention and antidepressant treatment in smoking cessation | Q43568906 | ||
Extended nortriptyline and psychological treatment for cigarette smoking | Q45130111 | ||
Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. | Q45938730 | ||
Statistical inference for cost-effectiveness ratios. | Q52265200 | ||
The usefulness of average cost-effective ratios | Q61876748 | ||
Clinical management--imipramine/placebo administration manual. NIMH Treatment of Depression Collaborative Research Program | Q68176260 | ||
A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives | Q73924114 | ||
P433 | issue | 4 | |
P304 | page(s) | 381-392 | |
P577 | publication date | 2005-10-01 | |
P1433 | published in | Journal of Behavioral Health Services and Research | Q15757216 |
P1476 | title | Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation. | |
P478 | volume | 32 |
Q34288059 | A multi‐level analysis of non‐significant counseling effects in a randomized smoking cessation trial |
Q24201167 | Antidepressants for smoking cessation |
Q84449266 | Assessing preferences for improved smoking cessation medications: a discrete choice experiment |
Q35751878 | Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence |
Q35217687 | Cost-effectiveness analysis of smoking-cessation counseling training for physicians and pharmacists |
Q35451969 | Cost-effectiveness of computed tomography screening for lung cancer in the United States |
Q28757732 | Effects of internet-based voucher reinforcement and a transdermal nicotine patch on cigarette smoking |
Q47140311 | Evaluation of smoking cessation intervention in patients with chronic diseases in smoking cessation clinics |
Q36150616 | From online randomized controlled trials to participant preference studies: morphing the San Francisco Stop Smoking site into a worldwide smoking cessation resource |
Q56212484 | Group behaviour therapy programmes for smoking cessation |
Q28277165 | New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline? |
Q37138047 | Nicotine abstinence genotyping: assessing the impact on smoking cessation clinical trials |
Q34602493 | Relationship between momentary affect states and self-efficacy in adolescent smokers |
Q33452790 | Smiling Instead of Smoking: Development of a Positive Psychology Smoking Cessation Smartphone App for Non-daily Smokers |
Q34779470 | The use of bupropion SR in cigarette smoking cessation |
Q47765206 | Why are antidepressant drugs effective smoking cessation aids? |